Skip to main content

Table 1 Follow-up of thyroid function in different hospitals

From: Drug-induced hypersensitivity syndrome induced by propylthiouracil: case report and literature review

Items

before

PTU

1 month

after stopping PTU

3 month

after stopping PTU

4 months

after stopping PTU

5 months

after stopping PTU

11 months

after stopping PTU

Hospital

A

B

C

C

C

C

TSH

0.01

0.07

0

6.81

34.93

1.16

 

0.27–4.20uIU/ml

0.34–5.6uIU/L

0.35–4.94mIU/L

FT3

15.25

3.5

6.55

   
 

3.1–6.80 pmol/L

3.8–6.0 pmol/L

1.71–3.71 pg/ml

FT4

71

16.2

2.23

   
 

12.00–22.00 pmol/L

7.9–17.1 pmol/L

0.70–1.48 ng/dl

TT3

5.46

0.94

2.42

0.86

0.76

1.32

 

1.3–3.10 nmol/L

1.05–2.73 nmol/L

0.57–1.59 ng/ml

TT4

239.7

99.79

13.06

4,75

3.68

8.88

 

66.00–181.00 nmol/L

78.38–170.0 nmol/L

4.87–11.72ug/dl

  1. A: local hospital; B: provincial hospital; C: our hospital
  2. FT3 free triiodothyronine, FT4 free thyroxine, PTU propylthiouracil, TSH thyroid stimulating hormone, TT3 total triiodothyronine, TT4 total thyroxin